Description
Zanamivir is an antiviral neuraminidase inhibitor that is used clinically to treat influenza virus infection. Zanamivir may also show some inhibitory activity against RNA virus infections as well.
Zanamivir
Product ID Z0252
Cas No. 139110-80-8
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 139110-80-8 |
|---|---|
| Purity | ≥98% |
| Formula | C12H20N4O7 |
| Formula Wt. | 332.31 |
| IUPAC Name | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2, 3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid |
| Synonym | 5-acetamido- 4-guanidino- 6-(1,2,3-trihydroxypropyl)- 5,6-dihydro- 4H-pyran- 2-carboxylic acid |
| Appearance | White to off white powder |
Shipping and Storage
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Kim JH, Resende R, Wennekes T, et al. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science. 2013 Apr 5;340(6128):71-5. PMID: 23429702.
Leyssen P, De Clercq E, Neyts J. Molecular strategies to inhibit the replication of RNA viruses. Antiviral Res. 2008 Apr;78(1):9-25. PMID: 18313769.